| Date | Product | Disease | Phase | Company | Therapeutic area |
|---|---|---|---|---|---|
| 2015-05-20 | tivozanib (N-{2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-N´-(5-methyl-3-isoxazolyl) urea hydrochloride monohydrate) | advanced renal cell carcinoma (RCC) |
2-3 | Aveo Oncology (USA - MA) | Cancer - Oncology |
| 2015-05-20 | tiotropium/olodaterol Respimat® | chronic obstructive pulmonary disease (COPD) |
3 | Boehringer Ingelheim (Germany) | Inflammatory diseases - Pulmonary diseases - Respiratory diseases |
| 2015-05-19 | abemaciclib (LY2835219) | non-small cell lung cancer (NSCLC) | 2 | Eli Lilly (USA - IN) | Cancer - Oncology |
| 2015-05-19 | prexasertib (LY2606368) | small cell lung cancer | 2 | Eli Lilly (USA - IN) | Cancer - Oncology |
| 2015-05-19 | sustained release triptorelin pamoate 22.5 mg 6-month-formulation | central precocious puberty (CPP) | 3 | Debiopharm (Switzerland) | Rare diseases - Endocrine diseases - Hormonal diseases |
| 2015-05-19 | GED-0301 (mongersen) | Crohn\'s disease |
2 | Celgene (USA - NJ) | Autoimmune diseases - Inflammatory diseases - Digestive diseases |
| 2015-05-19 | Reolysin® (pelareorep - human reovirus type 3 Dearing strain) | glioma |
1 | Oncolytics Biotech (Canada) | Cancer - Oncology |
| 2015-05-18 | dupilumab | uncontrolled moderate-to-severe asthma | 2b | Sanofi (France) Regeneron Pharmaceuticals (USA - NY) | Allergic diseases - Inflammatory diseases - Respiratory diseases |
| 2015-05-18 | Zephyr® Endobronchial Valve | severe emphysema |
Pulmonx (Switzerland - USA - CA) | Lung diseases - Respiratory diseases | |
| 2015-05-18 | Zephyr® Endobronchial Valve | severe emphysema |
Pulmonx (Switzerland - USA - CA) | Lung diseases - Respiratory diseases | |
| 2015-05-15 | 4Kscore® Test | prostate cancer | Opko Health (USA - Fl) | Cancer - Oncology - Diagnostic | |
| 2015-05-15 | ALD403 | prevention of frequent episodic migraine |
2 | Alder Biopharmaceuticals (USA - WA) | CNS diseases |
| 2015-05-15 | inhibitor of microRNA-145 (miR-145) delivered by TheraSilence™ technology platform | pulmonary arterial hypertension |
preclinical | Celsion (USA - NJ) | Rare diseases - Cardiovascular diseases |
| 2015-05-14 | SAGE-547 | super-refractory status epilepticus (SRSE) | 1-2 | Sage Therapeutics (USA - MA) | CNS diseases - Neurological diseases |
| 2015-05-14 | Tagrisso® -AZD9291 (osimertinib) and durvalumab (MEDI4736) | locally advanced or metastatic EGFR T790M+ non small cell lung cancer | 3 | AstraZeneca (UK) | Cancer - Oncology |
| 2015-05-14 | NeuroSTAT® (cyclosporine) | acute ischemic stroke | 2 | Neurovive Pharmaceutical (Sweden) | Cerebrovascular diseases |
| 2015-05-14 | HuCNS-SC human neural stem cells | thoracic spinal cord injury |
1-2 | StemCells (USA - CA) | Rare diseases - Regenerative medicine |
| 2015-05-13 | emixustat hydrochloride | degenerative retinal diseases | preclinical | Acucela (USA - MA) | Ophtalmological diseases |
| 2015-05-13 | house dust mite sublingual immunotherapy tablet (STG320) | house dust mite-associated allergic rhinitis | 3 | Stallergenes (France) now Ares Allergy Holding (UK) | Allergic diseases - Inflammatory diseases - Respiratory diseases |
| 2015-05-13 | MPDL3280A (atezolizumab) | patients with advanced or metastatic non-small cell lung cancer after platinum failure |
2 | Genentech, a member of Roche Group (USA - CA - Switzerland) | Cancer - Oncology |
